Refine by MP, party, committee, province, or result type.

Results 1-15 of 17
Sorted by relevance | Sort by date: newest first / oldest first

Health committee  Yes, I will.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  We haven't really defended any patents in Canada, because our U.S. colleagues were fortunate enough to get, or apply for, patents in the United States. In our world, it's not as much a patent issue as it is an evidence-based intellectual property issue. For instance, we have a way of stratifying people into low, moderate, or high risk that is built into our programs.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Thank you. That's a very good question. It's been our experience that when we've gone to present to workplace HR departments, and to CFOs of different large corporations, they all ask for the same thing. They ask for Canadian-centric proof that there will be improved outcomes, improved productivity, decreased absenteeism, and presenteeism.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  I think I'll take that as a compliment. Thank you. I just get a thrill from trying to build something new. I think it takes passion, really, and I have a passion for preventative care. I have a passion for trying to do something early on and changing the course of somebody's life before disease hits.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Interrupt me any time. Thank you.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  It's a private organization originally founded in the United States and now global.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  There are essentially two different ways that people enter the program. One is through employer-sponsored programs. Ninety per cent of organizations in the United States with more than 1,000 employees offer their employees a formal wellness and disease management program. The reason for that is there is a great return on investment in terms of improvements in direct and indirect health care expenditures.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Not at this point.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  It's only to say that those kinds of surveillance tools and databases, which track these results, are very helpful in proving which evidence-based tools and evidence-based treatments actually create positive health outcomes and a positive return on investment in terms of the expenditure on those treatments.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  We recently launched a program, wisely instituted by the Alberta government, for complex care patients. One of the questions on the complex care plan that we helped develop for complex care patients, which physicians go through with their patients, is “Do you have an end-of-life plan?”

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  I'll make a very short comment. I'm not a heart specialist but it goes to our training that we always feel better if we do something for a patient, and sometimes what we do is not always improving their quality of life.

April 25th, 2013Committee meeting

Dr. Saul Quint

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Sure I can. I apologize for going over. We have validated scales such as the workplace product impairment score. The workplace validated score is a screening test that identifies for participants whether they require a colonoscopy, a pap smear, etc. Lastly, there's a physician summary report, which has C-CHANGE guidelines incorporated into it, which directs the physician, in a polite way, to relook at the treatment of their patient to ensure they're being treated according—

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Sorry I went over my time.

April 25th, 2013Committee meeting

Dr. Saul Quint

Health committee  Thank you so much. I'd like to introduce myself. I am a family physician as well as the CEO of INTERxVENT Canada. Ours is a for-profit organization. From listening to the previous speaker, I would say that the difference between their funding and research, and what we do, makes a point that needs to be taken.

April 25th, 2013Committee meeting

Dr. Saul Quint